CLDX vs TYL · rev $37.0K vs P/E 89, rev $1.26B
Celldex Therapeutics Inc (CLDX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
CLDX currently screens at market cap $2.35B. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the CLDX and TYL stock pages for the full models.
Not investment advice.